Dreyfus Research Long/Short Equity Fund

  • Ticker: DLSAX
  • Product Code: 6116
  • CUSIP: 26202X694
Share Class:

Portfolio Manager/Sub-Investment Adviser

The fund's investment adviser is The Dreyfus Corporation (Dreyfus). Dreyfus has engaged its affiliate, The Boston Company Asset Management, LLC (TBCAM), to serve as the fund's sub-investment adviser. Investment decisions for the fund are made by members of TBCAM's global research team. The team members primarily responsible for managing the fund are Elizabeth Slover, Matthew D. Griffin, CFA, and Matthew T. Jenkin. This position has been held by Ms. Slover and Mr. Griffin since the fund's inception in July 2013 and by Mr. Jenkin since December 2015. Ms. Slover is a senior managing director at TBCAM, and is the director of TBCAM's global research team. Mr. Griffin is a managing director and portfolio manager at TBCAM, and is a member of TBCAM's global research team. Mr. Jenkin is a senior research analyst on TBCAM's global research team.

Top Holdings 2

Conagra Foods 2.24%
Cisco Systems 1.94%
Molson Coors Brewing, Cl. B 1.85%
Ulta Salon, Cosmetics & Fragrance 1.69%
Zimmer Biomet Holdings 1.60%
Occidental Petroleum 1.53%
Laboratory Corporation Of America Holdings 1.52%
Abbott Laboratories 1.48%
The TJX Companies 1.48%
Broadcom 1.46%

Portfolio Statistics

Number of Holdings 72
as of 06/30/16
Portfolio Turnover Rate 359.78%
as of fiscal year end 10/31/15
P/E Ratio 3 20.95
as of 05/30/16

Investors should consider the investment objectives, risks, charges, and expenses of the fund carefully before investing. Download a prospectus, or a summary prospectus, if available, that contains this and other information about the fund, and read it carefully before investing.

Notes & Disclosures
  1. Portfolio composition and allocation is as of 06/30/16 and is subject to change at any time. Totals may not be exact due to rounding. Negative exposures may represent short positions through derivatives.
  2. The holdings listed should not be considered recommendations to buy or sell a security. Large concentrations can increase share price volatility.
  3. Price/earnings for a stock is the ratio of the company's most recent month-end share price to the company's estimated earnings per share (EPS) for the current fiscal year. If a third-party estimate for the current year EPS is not available, Morningstar will calculate an internal estimate based on the most recently reported EPS and average historical earnings growth rates. Price/ earnings is one of the five value factors used to calculate the Morningstar Style Box. For portfolios, this historical P/E data point is calculated by taking an asset-weighted average of the earnings yields (E/P) of all the stocks in the portfolio and then taking the reciprocal of the result. Source: Morningstar
Choose a date range

Quick Links